UTHR — United Therapeutics Corp
In 2026 Q2, 9 of the 140 tracked hedge funds reported a position in United Therapeutics Corp (UTHR), worth $988.80M combined. Over the quarter 4 opened or added, 5 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $925.85M | 1.30% | -4.4% |
| Ardsley | $16.25M | 1.80% | -40% |
| VanEck | $15.73M | 0.00% | -15.4% |
| Quadrature | $9.40M | 0.08% | +389.7% |
| Persistent | $7.58M | 2.40% | +102.6% |
| Augustine | $5.36M | 1.10% | +65.6% |
| Emerald Mutual | $4.30M | 0.15% | -5.4% |
| IMC | $3.53M | 0.03% | -70.6% |
| Emerald | $795.95K | 0.02% | +37.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.